Reported 6 days ago
Pfizer Inc. has raised approximately $3.2 billion by selling shares of Haleon Plc, thereby reducing its stake in the UK consumer health company. The transaction involved selling 640 million shares at a 3.3% discount, bringing Pfizer's ownership down to 15%. This sale follows Pfizer's earlier divestment of over £2.8 billion worth of Haleon shares and aligns with ongoing trends of share sales among European companies.
Source: YAHOO